期刊文献+

肿瘤血管内皮抗原TEM8的HLA-2.1限制性低亲和性CTL表位预测及改造分析

Prediction and modification analysis of low-affinity HLA-2.1 restricted CTL epitopes derived from tumor endothelial marker 8
下载PDF
导出
摘要 目的 初步筛选肿瘤血管内皮标志物8(tumorendothelialmarker 8,TEM 8)HLA A2 1限制性低亲和性CTL表位,并预测修饰后的表位与HLA A2 1之间亲和性的变化。方法 采用超基序、3D QSAR、蛋白酶解预测等相结合的办法筛选HLA A2 1限制性低亲和性CTL表位,并通过氨基酸置换适当修饰,最后对部分候选的多肽进行分子动力学模拟。结果 筛选出8个低亲和性CTL候选表位,经修饰后的表位与HLA A2 1之间的亲和性均有不同程度的提高。结论 初步预测和修饰的表位系列可为下一步实验提供了依据。 Objective To screen the possible HLA-A2.1 restricted low-affinity CTL epitopes derived from TEM8 and to predict the possible change of the affinity between epitope and the HLA-A2.1 molecule when the epitope is modified. Methods HLA-A2.1 restricted low-affinity CTL epitopes were predicted by CTL epitope-prediction-software based on supermotif, 3D-QSAR and proteasome cleavage probability. The candidates were modified by amino acid substitution and analyzed by computer. Six peptides were modeled by molecular dynamic simulation program. Results Eight low-affinity CTL candidate epitopes were selected out, and the affinity of the modified epitopes with HLA-A2.1 improved. Conclusion These data are very valuable for further experiments.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第11期1106-1108,共3页 Journal of Third Military Medical University
基金 国家自然科学基金资助项目 ( 30 4 71579)~~
关键词 肿瘤血管内皮标志物 CTL 表位 分子动力学模拟 TEM8 CTL epitope molecular dynamic simulation
  • 相关文献

参考文献11

  • 1Rosenberg S A, Yang J C, Schwartzentruber D J, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma[J]. Nat Med, 1998, 4(3) : 321 - 327.
  • 2Nanda A, St Croix B. Tumor endothelial markers: new targets for cancer therapy[J]. Curr Opin Oncol, 2004, 16(1): 44-49.
  • 3Lin Z H, Wu Y Z, Wei Y L, et al. A Rapid Method for Quantitative Prediction of High Affinity CTL Epitopes: QSAR Studies on Peptides Having Affinity with The Class I MHC Molecular HLA-A * 0201[J]. Letters in Peptide Sci, 2003, 10( 1 ) : 15 - 23.
  • 4Nussbaum A K, Kuttler C, Tenzer S, et al. Using the World Wide Web for predicting CTL epitopes[J]. Curr Opin Immunol, 2003, 15(1) : 69 - 74.
  • 5Wang R X, Liu L, Lai L H, et al. SCORE: A new empirical method for estimating the binding affinity of a protein-ligand complex[J]. J Mol Model, 1998, 4(12): 379-394.
  • 6Tourdot S, Scardino A, Saloustrou E, et al. A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes[J]. Eur J Immunol, 2000, 30(12): 3411-3421.
  • 7Gross D A, Graff Dubois S, Opolon P, et al. High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy [ J ]. J Clin Invest,2004, 113(3): 425-433.
  • 8Valmori D, Fonteneau J F, Lizana C M, et al. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues[J]. J Immunol, 1998, 160(4): 1750-1758.
  • 9Huarte E, Sarobe P, Lu J, et al. Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements[J]. Clin Cancer Res, 2002, 8(7) : 2336 - 2344.
  • 10Croix B S, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium[J]. Science, 2000, 289(5482) : 1197- 1202.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部